Aluminum in antiperspirant is the active ingredient that reduces sweat. Current human evidence does not show that normal use causes breast cancer, and skin absorption appears tiny. Claims about Alzheimer’s disease aren’t backed by convincing product-specific evidence. Regulators in the United States and European Union allow assessed aluminum salts when products meet their rules. The practical cautions are simpler: use it on intact skin, stop if irritation develops, and ask a doctor first if you have kidney disease.
If you only want odor control, you don’t need aluminum. Deodorant targets odor; antiperspirant targets sweat. Our guide to choosing between antiperspirant and deodorant explains that distinction in practical terms.
What aluminum salts actually do
Antiperspirants commonly use aluminum chlorohydrate or aluminum-zirconium salts. They react near the openings of sweat ducts and form temporary plugs. Less sweat then reaches the skin’s surface.
Bretagne and colleagues modeled this process in a microfluidic sweat duct in Soft Matter in 2017. Aluminum ions aggregated the model sweat proteins into a plug. This was a lab model, not a study of long-term health in people. It explains how the product works, not whether every formula is safe.
The distinction on the label matters. The US Food and Drug Administration treats antiperspirants as over-the-counter drugs. Its monograph lists aluminum compounds as the active ingredients that may reduce underarm wetness. A product without one of these actives may control odor, but it does not work as an FDA-recognized antiperspirant.
How much aluminum gets through skin
A direct human measurement points to low absorption. De Ligt and colleagues used a traceable aluminum isotope in a roll-on formula in 2022. The study enrolled 12 healthy women. Six provided systemic absorption data, while six provided skin samples.
The researchers estimated that 0.00052% of the applied aluminum entered the body. That is about five parts per million of the applied dose. Most remained in the outer skin layers. The measurement was sensitive enough to separate the applied isotope from aluminum already present in the environment.
That number needs boundaries. The study was small, tested one representative formula, and measured exposure rather than disease. It cannot prove that every product has identical absorption or settle effects across decades. It does show that arguments based on large amounts passing through intact underarm skin need better evidence.
The European Scientific Committee on Consumer Safety reviewed newer exposure data in 2024. It found aluminum compounds safe at the assessed maximum levels for non-spray cosmetics. It also accepted spray uses under a particle-size condition. Its opinion did not cover nano forms. In the United States, the FDA regards an antiperspirant that meets its monograph conditions as safe and effective for over-the-counter use.
Does aluminum in antiperspirant cause breast cancer?
The pooled human evidence does not show an association. Trinh and colleagues combined seven case-control studies in Cancer Investigation in 2024. The pooled odds ratio was 0.96, with a 95% confidence interval from 0.78 to 1.17. An odds ratio of 1 would mean no difference.
The estimate does not prove zero risk. All seven studies looked backward after diagnosis, so recall and product classification can be imperfect. Most measured reported product use rather than absorbed aluminum. Results also varied across studies. The authors called for prospective cohort research, which would record use before disease develops.
One large study inside that evidence base is useful for scale. Mirick, Davis and Thomas interviewed 813 women with breast cancer and 793 controls in 2002. They found no increase with antiperspirant use, blade shaving, or applying a product within one hour of shaving.
A 2017 study by Linhart and colleagues found a contrary signal. It compared 209 cases with 209 controls. Women reporting underarm products several times daily from before age 30 had an odds ratio of 3.88. Yet its confidence interval ran from 1.03 to 14.66, showing considerable uncertainty. It also relied on memories of past use and grouped underarm cosmetic products together. Aluminum found in tissue could not show when it arrived or whether it caused cancer.
A pooled result should not erase a contrary study. It should put that result in context. Taken together, current human studies do not support changing antiperspirant solely to lower breast cancer risk. They also cannot exclude a small effect with the certainty of a large, long-term prospective study.
Alzheimer’s disease, kidneys and skin irritation
The product-specific Alzheimer’s evidence is thin and mixed. Graves and colleagues studied 130 matched case-control pairs in 1990. Any antiperspirant or deodorant use was not associated with Alzheimer’s disease. The aluminum-specific odds ratio was 1.6, with a 95% confidence interval from 1.04 to 2.4. The authors called their results provocative and inconclusive. Surrogates had to recall another person’s product use across many years.
That old study does not establish cause. Nor does finding aluminum in tissue prove where it came from or what it did. The much newer absorption study shows a small exposure route, but it was not designed to measure dementia.
Kidney disease is a separate caution. The FDA requires US antiperspirant labels to say that people with kidney disease should ask a doctor before use. The same monograph does not say antiperspirants cause kidney disease. If that warning applies to you, follow it rather than estimating your risk from a percentage online.
Local irritation is the clearer everyday downside. The FDA label says not to use antiperspirant on broken skin and to stop if rash or irritation occurs. A reaction does not prove an aluminum allergy because a finished product contains several ingredients.
A practical decision table
| Your situation | Sensible next step | Why | Limit |
|---|---|---|---|
| You want less underarm wetness | Use a regulated aluminum antiperspirant as labeled. | Aluminum salts are the active sweat-reducing ingredients. | Results and irritation vary by formula. |
| You only want less odor | Choose an aluminum-free deodorant. | There is no need to block sweat if wetness does not bother you. | It may not prevent damp clothing. |
| You are worried about breast cancer | Base the choice on sweat control and skin comfort. | The 2024 pooled human evidence found no association. | Case-control evidence cannot prove zero risk. |
| Your skin burns or develops a rash | Stop using that product and let the skin recover. Seek medical advice if it persists or returns. | Irritation is a recognized reason to stop. | The reaction alone cannot identify the ingredient responsible. |
| You have kidney disease | Ask your doctor before using it. | This follows the required FDA warning. | The warning is not proof of harm to healthy kidneys. |
| You use an aerosol | Keep it away from your face and mouth. | The FDA warns against breathing the spray. | Spray directions differ, so read the label. |
Use it with less avoidable irritation
- Read the active ingredient and directions. “Natural” and “aluminum-free” describe a formula, not how well it controls sweat.
- Apply only to intact underarm skin. If shaving leaves cuts or burning, wait until the skin is calm.
- Use the labeled amount. Extra layers are not evidence of extra protection.
- Follow the product’s timing instructions. Our guide explains why many antiperspirants are applied at night.
- Stop if a rash or persistent irritation appears. Repeated reactions deserve advice from a pharmacist or clinician.
If correct over-the-counter use still leaves you soaking through clothes, more product is not the best next experiment. A clinician can check for excessive sweating and discuss options that match its cause and severity.

Oscar Nascimento
Editorial writer, GlowUp Face
Oscar writes about evidence-based skin care, healthcare, looksmaxxing, and the social and economic research surrounding appearance.
Full profile and all articles →





